Exicure falls for 5th straight day after pricing stock deal

Exicure

19/12/2019 16:24

(Updates with pricing details)
    ** Exicure Inc  XCUR.O  shares fall as much as 8.5% to $2.71
after co prices follow-on
    ** XCUR recently off 5.7% to $2.79 and on course for 5th
straight session of declines
    ** Co offers 10 mln shares at $2.75, 7% discount to stock's
Weds close, for gross raise of $27.5 mln  urn:newsml:reuters.com:*:nBw1GBc6Na
    ** Offering upsized slightly from $25 mln targeted upon
launch; represents ~18% of co's free float of shares, per
Refinitiv data
    ** XCUR to use net proceeds further develop its cancer and
neurological drugs
    ** Guggenheim sole bookrunner for offering
    ** Avg rating among 4 analysts is "strong buy"; median PT is
$8.50 (Refinitiv data)
    ** With Thurs move, stock extends YTD loss to 21%

 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))